Multilevel Intervention for Precision Oncology
NCT06825715 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2653
Last updated 2026-07-07
Summary
The investigators are rolling out a 3 level intervention designed to improve the use of Precision Oncology at 8 VA medical centers. The 3 components of the intervention are 1: a short educational video for patients, 2: audit and feedback to providers on their Precision Oncology practice patterns, and 3: a change in the electronic medical record to make it easier to order and review results of Precision Oncology tests.
Conditions
- Advanced Cancers of the Prostate
- Cancers of the Lung
Interventions
- OTHER
-
Multilevel intervention
3 components: patient education video, provider audit/feedback, and EMR ordering change
Sponsors & Collaborators
-
VA Madison Health Care
collaborator UNKNOWN -
VA Pittsburgh Healthcare System
collaborator FED -
Martinsburg VA Medical Center
collaborator UNKNOWN -
VA Eastern Oklahoma Health Care
collaborator UNKNOWN -
New Orleans VA Medical Center
collaborator UNKNOWN -
Northport VA Medical Center
collaborator UNKNOWN -
Fargo VA Medical Center
collaborator FED -
VA Office of Research and Development
lead FED
Principal Investigators
-
Daniel J Becker, MD · VA NY Harbor Healthcare System, New York, NY
Study Design
- Allocation
- NA
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-07-02
- Primary Completion
- 2029-02-28
- Completion
- 2030-02-28
Countries
- United States
Study Locations
More Related Trials
-
68GA-PSMA-11 PET/CT Scan in Impacting Treatment Strategies for Patients With Prostate Cancer
NCT04050215 ·Status: COMPLETED ·Phase: PHASE2
-
Computer Planned Radiation Therapy in Treating Patients With Prostate Cancer
NCT00003104 ·Status: COMPLETED ·Phase: PHASE2
-
Toward a Comprehensive Supportive Care Intervention for Older or Frail Men With mCRPC
NCT04193657 ·Status: COMPLETED
-
Prostate Specific Membrane Antigen (PMSA)-Based PET Imaging of High Risk Prostate Cancer
NCT03976843 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Gallium-68 PSMA-11 PET in Participants With Prostate Cancer
NCT05034562 ·Status: WITHDRAWN ·Phase: PHASE2
-
Clinical Use of 68Ga PSMA-11 PET/CT in Diagnosing, Staging and Restaging Prostate Cancer
NCT05002465 ·Status: NO_LONGER_AVAILABLE
-
PRE-ProstAtectomy MRI-GuidEd Stereotactic Body RadioTherapy for High-Risk Prostate Cancer Trial (PREPARE SBRT)
NCT03663218 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Multicenter Randomized Trial of 68Ga-PSMA-11 PET/CT Based SRT After Radical Prostatectomy
NCT03582774 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
FDG-PET-Guided Metastasis Directed Radiation Therapy for the Treatment of Metastatic Hormone Sensitive Prostate Cancer, The PRTY Trial
NCT06244004 ·Status: RECRUITING ·Phase: PHASE2
-
Evaluating the Clinical Accuracy of Gallium-68 PSMA PET/CT Imaging in Patients With Biochemical Recurrence of Prostate Cancer
NCT03822845 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Optimizing Veteran-Centered Prostate Cancer Survivorship Care
NCT01900561 ·Status: COMPLETED ·Phase: NA
-
Functional Microscale Organotypic Assays to Predict Patient Response to Anti-Angiogenesis Therapies
NCT03387514 ·Status: TERMINATED ·Phase: PHASE2
-
Prostate SBRT for Locally Recurrent Prostate Cancer After Prior Radiotherapy
NCT03253744 ·Status: COMPLETED ·Phase: PHASE1
-
Hypo-Fractionated Radiation Therapy for Localized Prostate Cancer
NCT01677845 ·Status: TERMINATED ·Phase: PHASE1
-
Randomized Trial of PSMA PET Scan Before Definitive Radiation Therapy for Prostate Cancer
NCT04457245 ·Status: TERMINATED ·Phase: PHASE3
-
Hypofractionated Image Guided Proton Therapy for Low andIntermediate Risk Prostate Cancer
NCT02040610 ·Status: RECRUITING ·Phase: NA
-
Targeted Biopsies in Determining Response in Patients With Prostate Cancer Undergoing High-Dose-Rate Brachytherapy
NCT02597894 ·Status: WITHDRAWN ·Phase: NA
-
An Investigational Scan (68Ga-PSMA-11 PET) for the Imaging of Prostate Cancer
NCT04777071 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
[68Ga]Ga-PSMA-11 PET/CT in the Assessment of High Risk and Recurrent Prostate Cancer
NCT04484701 ·Status: ACTIVE_NOT_RECRUITING
-
PRISM: Patient Experiences With PET Imaging in Prostate Cancer
NCT06523777 ·Status: ACTIVE_NOT_RECRUITING
-
Gallium-68 Citrate PET Used in Prostate Cancer
NCT02391025 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Patient Decision-making About Precision Oncology in Veterans With Advanced Prostate Cancer
NCT05396872 ·Status: RECRUITING ·Phase: NA
-
Electronic Patient Self-Reported Outcomes to Improve Cancer Management and Patient Experiences
NCT02847715 ·Status: COMPLETED ·Phase: NA
-
PET/CT Characterization of Treatment Resistance
NCT05647564 ·Status: RECRUITING ·Phase: NA
-
Phase 2 Hypofractionation Study Using Proton Beam Therapy for Prostate Adenocarcinoma
NCT01709253 ·Status: COMPLETED ·Phase: NA